Abvc Biopharma Stock Investor Sentiment

ABVC Stock  USD 0.52  0.03  5.45%   
About 61% of ABVC Biopharma's investor base is looking to short. The analysis of the overall investor sentiment regarding ABVC Biopharma suggests that many traders are alarmed. The current market sentiment, together with ABVC Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use ABVC Biopharma stock news signals to limit their universe of possible portfolio assets.
  

ABVC Biopharma Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards ABVC Biopharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at www.macroaxis.com         
Acquisition by Ramsey Sally Judith of 450000 shares of ABVC Biopharma at 2.0 subject to Rule 16b-3
Macroaxis News
over a week ago at thelincolnianonline.com         
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024
news
over a week ago at globenewswire.com         
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
Macroaxis News: globenewswire.com
over three weeks ago at www.macroaxis.com         
Acquisition by Nirta Joseph of 10000 shares of ABVC Biopharma at 0.15 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
ABVC BioPharma Receives 50,000 in Incremental Licensing Fees, Boosting Total Payments to 346,000 Fro...
Yahoo News
over a month ago at globenewswire.com         
ABVC BioPharma Receives 50,000 in Incremental Licensing Fees, Boosting Total Payments to 346,000 Fro...
Macroaxis News: globenewswire.com
over a month ago at news.google.com         
ABVC BioPharma switches to new independent accounting firm - Investing.com
Google News at Macroaxis
over two months ago at thelincolnianonline.com         
Short Interest in ABVC BioPharma, Inc. Grows By 8.1
news
over two months ago at www.macroaxis.com         
Acquisition by Smith J.b. of 47000 shares of ABVC Biopharma at 0.75 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
ABVC Stock Earnings ABVC BioPharma Reported Results for Q2 2024 - MSN
Google News at Macroaxis
over three months ago at news.google.com         
ABVC BioPharma Releases Corporate Presentation Update - TipRanks
Google News at Macroaxis
over three months ago at investorplace.com         
ABVC Stock Earnings ABVC BioPharma Reported Results for Q2 2024
sbwire news
over three months ago at finance.yahoo.com         
ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
Yahoo News
over three months ago at news.google.com         
ABVC BioPharma, Inc. Short Interest Update - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
ABVC BioPharma Stock Price Down 7.6 percent - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about ABVC Biopharma that are available to investors today. That information is available publicly through ABVC media outlets and privately through word of mouth or via ABVC internal channels. However, regardless of the origin, that massive amount of ABVC data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ABVC Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ABVC Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ABVC Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ABVC Biopharma alpha.

ABVC Biopharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Smith J.b. of 47000 shares of ABVC Biopharma at 0.75 subject to Rule 16b-3
09/09/2024
2
Acquisition by Nirta Joseph of 10000 shares of ABVC Biopharma at 0.15 subject to Rule 16b-3
10/30/2024
3
Acquisition by Ramsey Sally Judith of 450000 shares of ABVC Biopharma at 2.0 subject to Rule 16b-3
11/25/2024

Complementary Tools for ABVC Stock analysis

When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity